INLB OTC
Item 9 Labs Corp.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -99.0%
1Y: -99.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±4955.7%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$22M
-0.8% ▼
5Y CAGR: +145.5%
Gross Profit
$7M
-15.1% ▼
5Y CAGR: +113.9%
Operating Income
-$23M
-311.8% ▼
Net Income
-$31M
-185.6% ▼
EPS (Diluted)
$-0.33
-135.7% ▼
EBITDA
-$23M
-424.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $1M | $5M | $8M | $22M | $22M |
| YoY Growth | +463.8% | +258.8% | +64.6% | +170.1% | -0.8% |
| Cost of Revenue | $1M | $3M | $5M | $13M | $14M |
| Gross Profit | $357K | $2M | $3M | $9M | $7M |
| Gross Margin | 26.0% | 48.2% | 40.6% | 39.3% | 33.6% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $503K | $5M | $6M | $11M | $19M |
| Operating Expenses | $1M | $7M | $9M | $14M | $30M |
| Operating Income | -$691K | -$4M | -$5M | -$6M | -$23M |
| Operating Margin | -50.3% | -88.8% | -65.6% | -25.5% | -106.0% |
| Interest Expense | $2K | $343K | $7M | $5M | $6M |
| Income Before Tax | -$664K | -$10M | -$12M | -$11M | -$31M |
| Tax Expense | $30K | $683K | -$86K | $0 | $13K |
| Net Income | -$642K | -$11M | -$12M | -$11M | -$31M |
| Net Margin | -46.7% | -215.5% | -151.4% | -49.7% | -143.1% |
| EPS (Diluted) | $-0.23 | $-0.17 | $-0.20 | $-0.14 | $-0.33 |
| EBITDA | -$604K | -$9M | -$4M | -$4M | -$23M |
| Shares Outstanding | 3M | 62M | 62M | 79M | 96M |